Dr. Schwartzman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
310 E 72nd St
New York, NY 10021Fax+1 646-650-3268
Summary
- Monica Schwartzman, MD, MS is a board certified rheumatologist practicing in New York
Education & Training
- Weill Cornell Medical CollegeMS, Clinical Epidemiology and Health Services Research, 2019 - 2021
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 2018 - 2021
- Icahn School of Medicine at Mount Sinai (Bronx)Residency, Internal Medicine, 2015 - 2018
- Icahn School of Medicine at Mount SinaiClass of 2015
- Cornell UniversityB.A, History, 2006 - 2010
Certifications & Licensure
- NY State Medical License 2018 - 2025
- CT State Medical License 2021 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 68 citationsPodocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal FailureMonica Schwartzman, Antoine Reginensi, Jenny Wong, John M. Basgen, Kristin Meliambro
Journal of the American Society of Nephrology. 2016-01-01 - 8 citationsDefining the phenotype, pathogenesis and treatment of Crohn's disease associated spondyloarthritis.Anand Kumar, Dana J. Lukin, Robert Battat, Monica Schwartzman, Lisa A. Mandl
Journal of Gastroenterology. 2020-05-04 - 9 citationsIs There a Role for MRI to Establish Treatment Indications and Effectively Monitor Response in Patients with Axial SpondyloarthritisMonica Schwartzman, Walter P. Maksymowych
Rheumatic Diseases Clinics of North America. 2019-06-05
Journal Articles
- Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure.Schwartzman M, Reginensi A, Wong JS, Basgen JM, Meliambro K, Nicholas SB, D'Agati V, McNeill H, Campbell KN, Journal of the American Society of Nephrology, 1/2016
Press Mentions
- Medication Preferences & Current Practices for PsAMay 11th, 2022
- HSS Study Provides Insight into Real-World Medication Use for Treatment of Psoriatic ArthritisNovember 9th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: